Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $358.85 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $147.94 | 1 | $0 (2021) |
| GlaxoSmithKline, LLC. | $147.35 | 4 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $35.28 | 2 | $0 (2019) |
| PFIZER INC. | $14.84 | 1 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $13.44 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $147.94 | 1 | Medtronic, Inc. ($147.94) |
| 2019 | $20.58 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($20.58) |
| 2018 | $32.69 | 2 | GlaxoSmithKline, LLC. ($17.99) |
| 2017 | $157.64 | 5 | GlaxoSmithKline, LLC. ($129.36) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/25/2021 | Medtronic, Inc. | Resolute (Device) | Food and Beverage | In-kind items and services | $147.94 | General |
| Category: Stents | ||||||
| 03/20/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: RESPIRATORY | ||||||
| 08/15/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: RESPIRATORY | ||||||
| 07/23/2018 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: RESPIRATORY | ||||||
| 11/01/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $12.42 | General |
| Category: RESPIRATORY | ||||||
| 06/15/2017 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $101.93 | General |
| Category: RESPIRATORY | ||||||
| 05/03/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/22/2017 | GlaxoSmithKline, LLC. | ANORO (Drug), INCRUSE | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: RESPIRATORY | ||||||
| 02/08/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 513 | 941 | $217,576 | $70,649 |
| 2022 | 11 | 713 | 1,222 | $304,499 | $92,983 |
| 2021 | 11 | 602 | 1,183 | $260,182 | $80,833 |
| 2020 | 3 | 153 | 191 | $24,702 | $8,714 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 182 | 567 | $105,462 | $35,286 | 33.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 150 | 157 | $42,704 | $14,102 | 33.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 81 | 84 | $29,400 | $8,578 | 29.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 36 | 68 | $18,020 | $6,404 | 35.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 29 | 30 | $15,480 | $4,117 | 26.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 35 | 35 | $6,510 | $2,161 | 33.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 157 | 472 | $87,792 | $27,131 | 30.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 122 | 299 | $79,235 | $24,256 | 30.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 164 | 171 | $46,512 | $14,239 | 30.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 75 | 76 | $39,216 | $11,918 | 30.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 35 | 36 | $12,600 | $3,873 | 30.7% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 59 | 59 | $10,974 | $3,283 | 29.9% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 17 | 17 | $8,041 | $2,385 | 29.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 20 | 27 | $7,371 | $2,122 | 28.8% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 16 | 16 | $5,552 | $1,686 | 30.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 36 | 36 | $4,788 | $1,415 | 29.6% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 12 | 13 | $2,418 | $675.69 | 27.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 195 | 687 | $127,782 | $39,446 | 30.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 49 | 126 | $33,390 | $10,615 | 31.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 108 | 111 | $30,192 | $9,471 | 31.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 54 | 54 | $18,900 | $5,994 | 31.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 25 | 28 | $14,448 | $4,330 | 30.0% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 51 | 52 | $9,672 | $2,903 | 30.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 41 | 42 | $7,812 | $2,446 | 31.3% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 23 | 23 | $6,003 | $1,887 | 31.4% |
About Dr. Cameron Esmkhani, DO
Dr. Cameron Esmkhani, DO is a Social Worker healthcare provider based in Zephyrhills, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/31/2008. The National Provider Identifier (NPI) number assigned to this provider is 1396922415.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Cameron Esmkhani, DO has received a total of $358.85 in payments from pharmaceutical and medical device companies, with $147.94 received in 2021. These payments were reported across 9 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($358.85).
As a Medicare-enrolled provider, Esmkhani has provided services to 1,981 Medicare beneficiaries, totaling 3,537 services with total Medicare billing of $253,179. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Practice Information
- Specialty Social Worker
- Other Specialties Internal Medicine, Internal Medicine
- Location Zephyrhills, FL
- Active Since 01/31/2008
- Last Updated 01/06/2021
- Taxonomy Code 104100000X
- Entity Type Individual
- NPI Number 1396922415
Products in Payments
- Resolute (Device) $147.94
- ANORO ELLIPTA (Drug) $101.93
- ANORO (Drug) $45.42
- SPIRIVA (Drug) $20.58
- ELIQUIS (Drug) $14.84
- STIOLTO RESPIMAT (Drug) $14.70
- JANUVIA (Drug) $13.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.